Mark Hanscom, MD
Gastroenterology · New York, NYNPI 1982095980
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 60.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $2,499 and has fallen 66.7% since, to $833 in 2025.
Across 49 payments — averaging $148.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Medtronic$1K
- Olympus Corporation Of The Americas$754
- Olympus America Inc.$249
- AbbVie$112
- Apollo Endosurgery US Inc$109
- plus $186 from 3 others
What the payments were for
- Consulting fees$1,32018%
- Travel & lodging$3,20444%
- Food & beverage$2,62136%
- Education$1352%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 32 | $4,394 |
| Medtronic | 4 | $1,478 |
| Olympus Corporation Of The Americas | 4 | $754 |
| Olympus America Inc. | 2 | $249 |
| AbbVie | 2 | $112 |
| Apollo Endosurgery US Inc | 2 | $109 |
| Conmed Corporation | 1 | $97 |
| Micro-tech Endoscopy USA, Inc. | 1 | $56 |
| Mahana Therapeutics, Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACQUIRE$1,501
- Apollo ESG NXT System$1,146
- Single Use Electrosurgical Knife KD-655$812
- VISIGLIDE$710
- DISPOSABLE DISTAL ATTACHMENT$710
- Olympus$710
- Single Use Aspiration Needle NA-U200H$423
- OverStitch Endoscopic Suturing System$169
- APOLLO ESG System$165
- GENERAL - BILIARY DEVICES$163
- EXALT Model D$153
- Single Use Repositionable Clip$147
- WallFlex Duodenal$126
- DISPOSABLE GRASPING FORCEPS$102
- EndoClot PHS$102
- EndoClot SIS$102
How this compares
$7,280 in reported general payments places this provider in the 70th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 14 | $291 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 16 | $257 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Caterina Oneto ArayaNew York$610K
- Dana LukinNew York$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.